{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:06:20Z","timestamp":1753891580334,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570849 LPC"],"award-info":[{"award-number":["81570849 LPC"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014857","name":"National Natural Science Foundation of China-Guangdong Joint Fund","doi-asserted-by":"publisher","award":["2020A1515011413 LPC"],"award-info":[{"award-number":["2020A1515011413 LPC"]}],"id":[{"id":"10.13039\/501100014857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This retrospective study aimed to investigate the clinical features of optic neuritis associated with COVID-19 (COVID-19 ON), comparing them with neuromyelitis optica-associated optic neuritis (NMO-ON), myelin oligodendrocyte glycoprotein-associated optic neuritis (MOG-ON), and antibody-negative optic neuritis (antibody-negative ON).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from 117 patients (145 eyes) with optic neuritis at the Shantou International Eye Center (March 2020\u2013June 2023) were categorized into four groups based on etiology: Group 1 (neuromyelitis optica-related optic neuritis, NMO-ON), Group 2 (myelin oligodendrocyte glycoprotein optic neuritis, MOG-ON), Group 3 (antibody-negative optic neuritis, antibody-negative ON), and Group 4 (optic neuritis associated with COVID-19, COVID-19 ON). Characteristics of T2 and enhancement in orbital magnetic resonance imaging (MRI) were assessed. Best-corrected visual acuity (BCVA) was compared before treatment, at a short-term follow-up (14 days), and at the last follow-up after treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The COVID-19-associated optic neuritis (COVID-19 ON) group exhibited 100% bilateral involvement, significantly surpassing other groups (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Optic disk edema was observed in 100% of COVID-19 ON cases, markedly differing from neuromyelitis optica-related optic neuritis (NMO-ON) (<jats:italic>P<\/jats:italic> = 0.023). Orbital magnetic resonance imaging (MRI) revealed distinctive long-segment lesions without intracranial involvement in T1-enhanced sequences for the COVID-19 ON group compared to the other three groups (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Discrepancies in optic nerve sheath involvement were noted between the COVID-19 ON group and both NMO-ON and antibody-negative optic neuritis (antibody-negative ON) groups (<jats:italic>P<\/jats:italic> = 0.028). Before treatment, no significant difference in best-corrected visual acuity (BCVA) existed between the COVID-19 ON group and other groups. At the 14-day follow-up, BCVA in the COVID-19 ON group outperformed the NMO-ON (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) and antibody-negative ON (<jats:italic>P<\/jats:italic> = 0.028) groups, with no significant difference observed compared to the myelin oligodendrocyte glycoprotein optic neuritis (MOG-ON) group. At the last follow-up after treatment, BCVA in the COVID-19 ON group significantly differed from the NMO-ON group (<jats:italic>P<\/jats:italic> &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Optic neuritis associated with COVID-19 (COVID-19 ON) predominantly presents with bilateral onset and optic disk edema. Orbital magnetic resonance imaging (MRI) demonstrates that COVID-19 ON presents as long-segment enhancement without the involvement of the intracranial segment of the optic nerve in T1-enhanced images. Glucocorticoid therapy showed positive outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1365465","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T04:18:10Z","timestamp":1712895490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical features of COVID-19-related optic neuritis: a retrospective study"],"prefix":"10.3389","volume":"15","author":[{"given":"Fang-Fang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Sheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyun","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kefan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Ping","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/S0140-6736(20)31014-X","article-title":"Retinal findings in patients with COVID-19","volume":"395","author":"Marinho","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/j.jcjo.2020.03.003","article-title":"Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19)","volume":"55","author":"Cheema","year":"2020","journal-title":"Can J Ophthalmol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"NP94","DOI":"10.1177\/1120672120974941","article-title":"Atypical bilateral acute retinal necrosis in a coronavirus disease 2019 positive immunosuppressed patient","volume":"32","author":"Gupta","year":"2020","journal-title":"Eur J Ophthalmol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"NP97","DOI":"10.1177\/1120672120977817","article-title":"Serpiginous choroiditis presenting after SARS-CoV-2 infection: a new immunological trigger?","volume":"32","author":"Provid\u00eancia","year":"2020","journal-title":"Eur J Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.931665","article-title":"Unilateral optic neuritis associated with SARS-CoV-2 infection: a rare complication","author":"Deane","year":"2021","journal-title":"Am J Case Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2324709620976018","article-title":"COVID-19-induced acute bilateral optic neuritis","volume":"8","author":"Sawalha","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s13365-021-00959-z","article-title":"Optic neuritis following SARS-CoV-2 infection","volume":"27","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2021","journal-title":"J NeuroVirol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/ijo.IJO_2235_21","article-title":"COVID-19-associated optic neuritis \u2013 A case series and review of literature","volume":"70","author":"Deb","year":"2022","journal-title":"Ind J Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101320","DOI":"10.1016\/j.inat.2021.101320","article-title":"Optic neuritis post-COVID-19 infection. a case report with meta-analysis","volume":"26","author":"Azab","year":"2021","journal-title":"Interdiscipl Neurosurg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.4103\/ijo.IJO_2155_21","article-title":"Acute bilateral retrobulbar optic neuritis - an atypical sequela of COVID-19","volume":"69","author":"Krishnagopal","year":"2021","journal-title":"Ind J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1017\/cjn.2021.183","article-title":"Optic neuritis associated with SARS-CoV-2 B117 variant of concern","volume":"49","author":"Micieli","year":"2021","journal-title":"Can J Neurol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1212\/CON.0000000000000777","article-title":"Infectious optic neuropathies","volume":"25","author":"Eggenberger","year":"2019","journal-title":"CONTINUUM."},{"key":"B14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1212\/CPJ.0000000000000583","article-title":"Bilateral optic neuritis from acute HIV infection","volume":"9","author":"Fortin","year":"2019","journal-title":"Neurol Clin Pract"},{"key":"B17","first-page":"1812","article-title":"\u6c34\u75d8-\u5e26\u72b6\u75b1\u75b9\u75c5\u6bd2\u611f\u67d3\u76f8\u5173\u89c6\u795e\u7ecf\u75c5\u53d8\u4e94\u4f8b\u4e34\u5e8a\u5206\u6790","author":"\u5b5f\u8d85","year":"2020"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archopht.125.10.1381","article-title":"Optic neuritis associated with Chikungunya virus infection in South India","volume":"125","author":"Apoorva Mittal","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.ijid.2010.10.004","article-title":"Acute optic neuritis following infection with chikungunya virus in southern rural India","volume":"15","author":"Rose","year":"2011","journal-title":"Int J Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"102838","DOI":"10.5812\/archcid.102838","article-title":"The potential use of persian herbal medicines against COVID-19 through angiotensin-converting enzyme 2","volume":"15","author":"Heidary","year":"2020","journal-title":"Arch Clin Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.17879\/freeneuropathology-2021-2993","article-title":"Neuropathology of COVID-19 (neuro-COVID): clinicopathological update","volume":"2","author":"Lou","year":"2021","journal-title":"Free Neuropathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"975","DOI":"10.5005\/jp-journals-10071-23592","article-title":"Pathophysiological mechanisms and neurological manifestations in COVID-19","volume":"24","author":"Gupta","year":"2021","journal-title":"Ind J Crit Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2010.10.013","article-title":"A serological analysis of viral and bacterial infections associated with neuromyelitis optica","volume":"300","author":"Koga","year":"2011","journal-title":"J Neurol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2147\/IMCRJ.S267867","article-title":"Clinical characteristics of HIV-associated optic neuritis","volume":"13","author":"Jindahra","year":"2020","journal-title":"Int Med Case Rep J"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1365465\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T04:18:13Z","timestamp":1712895493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1365465\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":26,"alternative-id":["10.3389\/fneur.2024.1365465"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1365465","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2024,4,12]]},"article-number":"1365465"}}